Although previous studies reported that type I transmembrane collagen receptor Endo180 (CD280, CLEC13E, KIAA0709, MRC2, TEM9 or uPARAP) was a strong prognostic indicator for PC survival [27], this is the first time that its role in PC aggressiveness is proved in blood. This evidence concerns the gene MRC2 and pachyonychia congenita.